Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein—Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue
Andreas M. Kogelnik, Kristin Loomis, Mette Hoegh-Petersen, Fernando Rosso, Courtney Hischier, Jose G. MontoyaVolume:
37
Year:
2006
Language:
english
DOI:
10.1016/s1386-6532(06)70009-9
File:
PDF, 303 KB
english, 2006